3,4-dihydroxyphenylacetic acid has been researched along with Gelineau Syndrome in 9 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The other had the sole symptom of excessive daytime sleepiness, confirmed by sleep latency tests, which was unaccompanied by systemic illness." | 1.27 | Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. ( Barchas, JD; Berger, PA; Faull, KF; Guilleminault, C, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Krief, S | 1 |
| Berrebi-Bertrand, I | 1 |
| Nagmar, I | 1 |
| Giret, M | 1 |
| Belliard, S | 1 |
| Perrin, D | 1 |
| Uguen, M | 1 |
| Robert, P | 1 |
| Lecomte, JM | 1 |
| Schwartz, JC | 1 |
| Finance, O | 1 |
| Ligneau, X | 1 |
| Faull, KF | 5 |
| Barchas, JD | 4 |
| Foutz, AS | 3 |
| Dement, WC | 5 |
| Holman, RB | 2 |
| Mefford, IN | 1 |
| Baker, TL | 1 |
| Boehme, R | 1 |
| Ciaranello, RD | 2 |
| Guilleminault, C | 2 |
| Berger, PA | 1 |
| Nishino, S | 1 |
| Fujiki, N | 1 |
| Ripley, B | 1 |
| Sakurai, E | 1 |
| Kato, M | 1 |
| Watanabe, T | 1 |
| Mignot, E | 1 |
| Yanai, K | 1 |
| Faull, K | 1 |
| Miller, JD | 1 |
| Bowersox, SS | 2 |
| Thiemann, S | 1 |
| King, RJ | 1 |
| Kilduff, TS | 1 |
| Zeller-DeAmicis, L | 1 |
9 other studies available for 3,4-dihydroxyphenylacetic acid and Gelineau Syndrome
| Article | Year |
|---|---|
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corp | 2021 |
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dogs; Homovanillic Acid; Humans; Hydroxyin | 1982 |
Narcolepsy: biogenic amine deficits in an animal model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Disease Models, Animal; Dogs; Dopamine; Ep | 1983 |
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Amino Acids; Disorders of Excessive Somnolence; Female; | 1983 |
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Cerebral Cortex; Chromatography, Hi | 2001 |
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dogs; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1979 |
CNS monoamines and their metabolites in canine narcolepsy: a replication study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Disease Models, Animal; Dogs; Dopamine; Hydroxyindol | 1990 |
Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Amines; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxy | 1986 |
Brain dopamine receptor levels elevated in canine narcolepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain Chemistry; Caudate Nucleus; Dogs; Dopamine; | 1987 |